Related Experiment Video

Updated: Jul 16, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

[Infectious diseases (beside AIDS)]

G Zanetti1

  • 1Service de médecine preventive, hospitalière et Service des maladies infectieuses, CHUV, Lausanne. Giorgio.Zanetti@chuv.ch

Revue Medicale Suisse
|March 16, 2007
PubMed

Insights

Global health surveillance identifies emerging infectious disease threats like H5N1 influenza and resistant bacteria. Strategies focus on rational antibiotic use and new vaccines, such as for human papillomavirus (HPV), to combat these challenges.

Area of Science:

  • Epidemiology
  • Infectious Diseases
  • Public Health

Background:

  • Influenza A H5N1 shows pandemic potential despite not adapting to humans.
  • Chikungunya virus is spreading across the Indian Ocean region.
  • Drug-resistant Staphylococcus aureus is increasingly prevalent.
  • A virulent Clostridium difficile strain is emerging in North America and Europe.

Purpose of the Study:

  • To summarize key epidemiological developments in infectious diseases.
  • To highlight emerging therapeutic strategies and advancements.

Main Methods:

  • Review of current epidemiological data on significant infectious agents.
  • Analysis of therapeutic approaches, including antibiotic stewardship and vaccination.

Main Results:

  • Continued spread of Influenza A H5N1 with pandemic potential.
  • Geographic expansion of Chikungunya.
  • Increased prevalence of resistant Staphylococcus aureus.
  • Emergence of a virulent Clostridium difficile strain.
  • Limited new therapeutic developments, emphasizing rational antibiotic use.
  • Availability of a new human Papillomavirus (HPV) vaccine for cervical cancer prevention.

Conclusions:

  • The landscape of infectious diseases is dynamic, with notable threats requiring vigilance.
  • Current therapeutic focus is on optimizing existing treatments and preventative measures like vaccination.

More Related Videos

Peptide-based Identification of Functional Motifs and their Binding Partners14:28

Peptide-based Identification of Functional Motifs and their Binding Partners

Published on: June 30, 2013

Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients13:50

Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients

Published on: June 11, 2011

Related Concept Videos

Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
Infection01:20

Infection

When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...